Literature DB >> 18979266

Motesanib diphosphate (AMG 706), an oral angiogenesis inhibitor, demonstrates clinical efficacy in advanced thymoma.

Arun Azad, Rebecca A Herbertson, David Pook, Shane White, Paul L R Mitchell, Niall C Tebbutt.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2009        PMID： 18979266     DOI： 10.1080/02841860802495362

Source DB:  PubMed          Journal:  Acta Oncol        ISSN： 0284-186X            Impact factor:   4.089


× No keyword cloud information.
  5 in total

1.  Platelet-derived growth factor and platelet-derived growth factor receptor-α expression in the normal human thymus and thymoma.

Authors:  Anca Maria Cimpean; Raluca Ceauşu; Svetlana Encică; Pusa Nela Gaje; Domenico Ribatti; Marius Raica
Journal:  Int J Exp Pathol       Date:  2011-06-07       Impact factor: 1.925

Review 2.  Thymoma and thymic carcinoma.

Authors:  Federico Venuta; Erino A Rendina; Marco Anile; Tiziano de Giacomo; Domenico Vitolo; Giorgio F Coloni
Journal:  Gen Thorac Cardiovasc Surg       Date:  2012-01-13

3.  Thymic neoplasm: a rare disease with a complex clinical presentation.

Authors:  Omar M Rashid; Anthony D Cassano; Kazuaki Takabe
Journal:  J Thorac Dis       Date:  2013-04       Impact factor: 2.895

Review 4.  The clinical features, diagnosis and management of recurrent thymoma.

Authors:  Taobo Luo; Hongguang Zhao; Xinming Zhou
Journal:  J Cardiothorac Surg       Date:  2016-08-31       Impact factor: 1.637

Review 5.  [Treatment of Recurrent Thymoma].

Authors:  Xianping Liu; Xiao Li; Jianfeng Li
Journal:  Zhongguo Fei Ai Za Zhi       Date:  2020-02-27
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.